To see more articles like this, follow Komodo Health on LinkedIn, YouTube, or X, and visit our Resources Hub.
Additionally, over 80% of patients in real-world settings stay on lower maintenance doses typically 1 mg or less for semaglutide and 7.5 mg or less for tirzepatide
If side effects feel severe or dont improve, its best to check in with your healthcare provider
Some insurers also demand prior authorization, documentation of failed weight loss attempts, and proof that lifestyle modifications alone have not worked
On April 1, 2026, the FDA reiterated its enforcement policy: it does not currently intend to take action where a 503A compounder fills four or fewer prescriptions per calendar month of a drug that is "essentially a copy." That safe harbor is narrow, and it signals the FDA's direction